Autologous hematopoietic cell transplantation in non-Hodgkin's lymphoma

Hematology/Oncology Clinics of North America

Volumn 13, Issue 5, 1999, Pages 889-918

  Johnston, L J ^a   Homing, S J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; MELPHALAN; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RELAPSE; REVIEW; TREATMENT OUTCOME;

EID: 0032831890     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70102-7     Document Type: Article

References (124)

1. N.S. Andersen J.W. Donovan J.S. Borus Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease Blood 90 1997 4212 4221
2. S. Ansell T. Habermann P. Kurtin Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma J Clin Oncol 15 1997 2296 2301
3. J. Armitage D. Weisenburger New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes J Clin Oncol 16 1998 2780 2795
4. J. Armitage D. Weisenburger M. Hutchins Chemotherapy for diffuse large-cell lymphoma—Rapidly responding patients have more durable remissions J Clin Oncol 4 1986 160 164
5. J.O. Armitage Management of mantle cell lymphoma Oncology 12 1998 49 55
6. Y. Bastion P. Brice C. Haïoun Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma Blood 86 1995 3257 3262
7. J. Bernstein N. Coleman J. Strickler Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types) J Clin Oncol 4 1986 847
8. P. Bierman J. Vose J. Anderson High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma J Clin Oncol 15 1997 445 450
9. R. Bigler P. Crilley H. Micaily Autologous bone marrow transplantation for advanced stage mycosis fungoides Bone Marrow Transplant 7 1991 133 137
10. J. Blay F. Gomez T. Bachelot The international prognostic index correlates to survival in intermediate/high grade lymphoma in relapse: Analysis of the Parma Trial Proceedings of the American Society of Clinical Oncology 15 1996 151
11. A. Bosly A. Sonet G. Salles Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93 Blood 90 suppl 1 1997 594a
12. P. Brice Y. Bastion E. Lepage Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: A randomized study from the Groupe D'Etude des Lymphomes Folliculaires J Clin Oncol 15 1997 1110 1117
13. P. Brice D. Simon R. Bouabdallah Autologous stem cell transplantation improves survival after progression for patients with a follicular lymphoma (GELF 86 Protocols) Blood 92 suppl 1 1998 464a
14. P. Carbone H. Kaplan K. Musshoff Report of the Committee on Hodgkin's Disease Staging Classification Cancer Res 31 1971 1860 1861
15. F. Cervantes X. Shu P. McGlave Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma Bone Marrow Transplant 16 1995 387 392
16. B. Cheson S. Horning B. Coiffier Report of an International workshop to standardize response criteria for non-Hodgkin's lymphomas J Clin Oncol 17 1999 1244 1253
17. B. Coiffer C. Gisselbrecht J. Vose Prognostic factors in aggressive malignant lymphoma: Description and validation of a prognostic index that could identify patients requiring a more intensive therapy J Clin Oncol 9 1991 211
18. B. Coiffier Y. Bastion F. Berger Prognostic factors in follicular lymphomas Semin Oncol 20 suppl 5 1993 89 95
19. C. Coleman V. Picozzi R. Cox Treatment of lymphoblastic lymphoma in adults J Clin Oncol 4 1986 1628 1637
20. P. Colombat D. Donadio L. Fouillard Value of autologous bone marrow transplantation in follicular lymphoma: A France Autogreffe retrospective study of 42 patients Bone Marrow Transplant 13 1994 157 162
21. E. Conde F. Bosch R. Arranz Autologous stem cell transplantation for mantle cell lymphoma. The experience of the GEL/TAMO Spanish Cooperative Group Blood 92 suppl 1 1998 464a
22. E. Conde J. Lahuerta J. Sierra Autologous stem cell transplantation for follicular lymphoma. The experience of the GEL/TAMO Spanish Cooperative Group Blood 92 suppl 1 1998 464a
23. M. Czuczman A. Grillo-López C. White Treatment of patients with low-grade B-cell lymphoma with combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy J Clin Oncol 17 1999 268 276
24. D.L. Darrington J.M. Vose J.R. Anderson Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies J Clin Oncol 12 1994 2527 2534
25. P. Dreger N. von Neuhoff R. Kuse Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma Ann Oncol 8 1997 401 403
26. R. Fanin F. Silvestri A. Geromin Sequential intensive treatment with the F-MACHOP regimen (± radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)–positive anaplastic large cell lymphoma in adults Leuk Lymphoma 24 1997 369 377
27. R. Fisher S. Dahlberg B. Nathwani A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group Study Blood 85 1995 1075 1082
28. R. Fisher E. Gaynor S. Dahlberg Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma N Engl J Med 328 1993 1002 1006
29. L. Fouillard N. Gorin J. Laporte Feasibility of autologous bone marrow transplantation for early consolidation of follicular non-Hodgkin's lymphoma Eur J Haematol 46 1991 279
30. A. Freedman J. Gribben D. Neuberg Long-term prolongation of disease-free and overall survival following autologous bone marrow transplantation in patients with advanced relapsed follicular lymphoma [abstract 2641] Proceedings of the American Society of Clinical Oncology 16 1997 89a
31. A. Freedman J. Gribben D. Neuberg High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission Blood 88 1996 2780 2786
32. A. Freedman J. Ritz D. Neuberg Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma Blood 77 1991 2524 2529
33. A. Freedman T. Takvorian K. Anderson Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: Very low treatment-related mortality in 100 patients in sensitive relapse J Clin Oncol 8 1990 784 791
34. A.S. Freedman D. Neuberg J.G. Gribben High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: No evidence for long-term remission [see comments] J Clin Oncol 16 1998 13 18
35. A. Gianni M. Bregni S. Siena High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma N Engl J Med 336 1997 1290 1297
36. R. Gressin E. Legouffe D. Leroux Treatment of mantle-cell lymphomas with the VAD ± chlorambucil regimen with or without subsequent high-dose therapy and peripheral blood stem-cell transplantation Ann Oncol 8 suppl 1 1997 103 106
37. C. Gugleilmi S. Amadori L. Ruco Combination chemotherapy for the treatment of diffuse aggressive lymphomas: F-MACHOP update Semin Oncol 14 1987 104 109
38. C. Guglielmi F. Gomez T. Philip Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma Trial J Clin Oncol 16 1998 3264 3269
39. S. Gulati B. Shank P. Black Autologous bone marrow transplantation for patients with poor prognosis lymphoma J Clin Oncol 6 1988 1303 1313
40. S. Gulati J. Yahalom L. Acaba Treatment of patient with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation J Clin Oncol 10 1992 936 941
41. R. Haas G. Brittinger P. Meusers Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma Leukemia 10 1996 1975 1979
42. R. Haas S. Hohaus G. Egerer Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest Bone Marrow Transplant 9 1992 459 465
43. R. Haas M. Moos R. Möhle High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma Bone Marrow Transplant 17 1996 149 155
44. C. Haïoun E. Lepage C. Gisselbrecht Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2 J Clin Oncol 15 1997 1131 1137
45. C. Haïoun E. Lepage C. Gisselbrecht Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: A study of 464 patients J Clin Oncol 12 1994 2543 2551
46. C. Haïoun E. Lepage C. Gisselbrecht High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma Ann Oncol 9 suppl 1 1998 S5 S8
47. N. Harris S. Elaine H. Stein A revised European-American classification of lymphoid (REAL) neoplasms: A proposal from the International Lymphoma Study Group Blood 84 1994 1361 1392
48. O. Hartmann A.G. Le Corroller D. Blaise Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: Hematologic recovery and costs. A randomized, controlled trial Ann Intern Med 126 1997 600 607
49. R. Haw C. Sawka E. Franssen Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: A literature review J Clin Oncol 12 1994 1074 1084
50. C. Hoh J. Glaspy P. Rosen Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma J Nucl Med 38 1997 343
51. S. Horning Natural history of and therapy for the indolent non-Hodgkin's lymphomas Semin Oncol 20 1993 75 88
52. S. Horning R. Negrin R. Hoppe High dose therapy and autografting for follicular low grade lymphoma in first remission: The Stanford experience Blood 90 suppl 1 1997 594a
53. F. Hsu C. Caspar D. Czerwinski Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma–Long-term results of a clinical trial Blood 89 1997 3129 3135
54. P. Johnson A. Rohatiner J. Whelan Patterns of survival in patients with recurrent follicular lymphoma: A 20-year study from a single center J Clin Oncol 13 1995 140 147
55. U. Kaiser I. Uebelacker K. Havemann High dose chemotherapy with autologous stem cell transplantation in high grade NHL: First analysis of a randomized multicenter study Bone Marrow Transplant 21 suppl 1 1998 S177
56. W. Kaplan M. Jachelson T. Herman Gallium-67 imaging: A predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma J Clin Oncol 8 1990 1966 1970
57. N. Ketterer G. Salles D. Espinouse Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma Ann Oncol 8 1997 701 704
58. I. Khouri J. Kantarjian W. Pugh Preliminary report of an active regimen for mantle cell lymphoma Blood 90 suppl 1 1997 248a
59. J. Kluin-Nelemans V. Zagonel J. Thomas Consolidation ABMT after standard chemotherapy vs CHVmP/BV alone for primary intermediate and high grade NHL: A randomized phase III EORTC study Proceedings of ASCO 18 1999 2a
60. A. Krishnan S. Bhatia R. Bhatia Risk factors for development of therapy-related leukemia (t-MDS/t-AML) following autologous transplantation (ABMT) Blood 92 suppl 1 1998 493a
61. N. Kröger M. Hoffknecht P. Dreger Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy Bone Marrow Transplant 21 1998 55 57
62. S. Landis T. Murray S. Bolden Cancer Statistics, 1999 CA Cancer J Clin 49 1999 8 31
63. K. Lennert Malignant Lymphomas Other Than Hodgkin's Disease 1978 Springer-Verlag New York
64. K. Lennert N. Mohri H. Stein The histopathology of malignant lymphoma Br J Haematol 31 suppl 1 1975 193 204
65. T. Lister D. Crowther S. Sutcliffe Report of committee convened to discuss the evaluation of staging of patients with Hodgkin's disease: Cotswolds meeting J Clin Oncol 7 1989 1630 1636
66. S.Y. Liu J.F. Eary S.H. Petersdorf Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue J Clin Oncol 16 1998 3270
67. D. Longo P. Duffey E. Jaffe Diffuse small non-cleaved cell, Burkitt's lymphoma in adults: A high grade lymphoma responsive to ProMACE-based combination chemotherapy J Clin Oncol 12 1994 2153 2159
68. R. Lukes R. Collins Immunologic characterization of human malignant lymphomas Cancer 34 1974 1488 1503
69. I. Magrath M. Adde A. Shad Adults and children with small non–cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen J Clin Oncol 14 1996 925 934
70. I. Majolino R. Pearce G. Taghipour Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: A new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation J Clin Oncol 15 1997 509 517
71. D. Maloney A. Grillo-Lopez C. White IDEC-C2B8 (Rituximab) Anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma Blood 90 1997 2188 2195
72. M. Martelli M. Vignetti P. Zinzani High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: A prospective randomized Italian multicenter study J Clin Oncol 14 1996 534 542
73. D. Martin M. Moos M. Voso High-dose therapy with peripheral blood stem cell transplantation in patients with low-grade non-Hodgkin's lymphoma Blood 92 suppl 1 1998 460a
74. P. McLaughlin A.J. Grillo-López B.K. Link Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program J Clin Oncol 16 1998 2825 2833
75. J.S. Miller D.C. Arthur C.E. Litz Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy [see comments] Blood 83 1994 3780 3786
76. D. Milligan M. Ruiz de Elivira A. Goldstone Secondary leukemia and myelodysplasia after autografting for lymphoma: Results from the EBMT Blood 92 suppl 1 1998 493a
77. A. Nademanee A. Molina M. O'Donnell Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: International index high and high-intermediate risk group Blood 90 1997 3844 3852
78. A. Nademanee A. Molina E. Smith High-dose therapy and autologous peripheral blood stem transplantation during first remission in patients with advanced stages and poor-prognosis mantle cell lymphoma Blood 88 suppl 1 1996 121a
79. A. Nademanee G. Schmidt M. O'Donnell High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: A pilot study Blood 80 1992 1130 1134
80. R.S. Negrin C.R. Kusnierz-Glaz B.J. Still Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma Blood 85 1995 3334 3341
81. S. Oddou N. Vey P. Viens Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: A report of six cases in a cohort of 171 patients from a single institution Leuk Lymphoma 31 1998 187 194
82. R. Pettengell G.R. Morgenstern P.J. Woll Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis Blood 82 1993 3770 3777
83. R. Pettengell J. Radford G. Morgenstern Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma J Clin Oncol 14 1996 586 592
84. T. Philip J. Armitage G. Spitzer High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma N Engl J Med 316 1987 1493 1498
85. T. Philip F. Gomez C. Guglielmi Long-term outcome of relapsed non-Hodgkin's lymphoma patients included in the PARMA trial: Incidence of late relapses, long-term toxicity and impact of the international prognostic index at relapse Proceedings of the American Society of Clinical Oncology 17 1998 16a
86. T. Philip C. Guglielmi A. Hagenbeek Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma N Engl J Med 333 1995 1540 1545
87. T. Philip O. Hartmann P. Biron High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma J Clin Oncol 6 1988 1118 1124
88. V. Picozzi C. Coleman Lymphoblastic lymphoma Semin Oncol 17 1990 96 103
89. O.W. Press F.R. Appelbaum J.F. Eary Radiolabeled antibody therapy of lymphomas Important Adv Oncol 76 1995 157 171
90. O. Press T. Grogan R. Fisher Evaluation and Management of Mantle Cell Lymphoma Advances in Leukemia and Lymphoma 6 1996 1 12
91. J. Radich T. Gooley J. Sanders Second allogeneic transplants after failure of autologous first transplant Blood 92 suppl 1 1998 494a
92. A. Rahmouni C. Tempany R. Johnes Lymphoma: Monitoring tumor size and signal intensity with MR imaging Radiology 188 1993 445 451
93. H. Rappaport W. Winter E. Hicks Follicular lymphoma: A re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases Cancer 9 1956 792 821
94. F. Reyes E. Lepage P. Morel Failure of first-line inductive high-dose chemotherapy (HDC) in poor-risk patients with aggressive lymphoma: Updated results of the randomized LNH93-3 study Blood 90 suppl 1 1997 594a
95. N. Robinson M. Benyunes J. Thompson Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: A phase I/II study Bone Marrow Transplant 19 1997 435 442
96. E. Rodriguez-Monge F. Cabanillas Long-term follow-up of platinum-based lymphoma salvage regimens. The M. D. Anderson Cancer Center experience Hematol Oncol Clin North Am 11 1997 937 947
97. A. Rohatiner P. Johnson C. Price Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma J Clin Oncol 12 1994 1177 1184
98. G. Santini P. Coser T. Chisesi Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. Report of the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG) Ann Oncol 2 suppl 2 1991 181 185
99. G. Santini L. Salvagno P. Leoni VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: Results of a prospective randomized trial by the Non-Hodgkin's Lymphoma Cooperative Study Group J Clin Oncol 16 1998 2796 2802
100. D. Schenkein P. Dixon J. Desforges Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease J Clin Oncol 12 1994 2423 2431
101. M. Shipp M. Abeloff K. Antman International Consensus Conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the Jury J Clin Oncol 17 1999 423 429
102. T.J. Smith B.E. Hillner N. Schmitz Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma J Clin Oncol 15 1997 5 10
103. M.A. Socinski S.A. Cannistra A. Elias Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man Lancet 1 1988 1194 1198
104. C. Soussain C. Patte M. Ostronoff Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMN pediatric protocols Blood 85 1995 664 674
105. D.A. Stewart J.M. Vose D.D. Weisenburger The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma Ann Oncol 6 1995 263 266
106. K.E. Stockerl-Goldstein S.J. Horning R.S. Negrin Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma Biol Blood Marrow Transplant 2 1996 76 85
107. R.M. Stone D. Neuberg R. Soiffer Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma J Clin Oncol 12 1994 2535
108. F. Suzan C. Belanger V. Ribrag Preliminary report of a strategy assessing a CHOP-regimen and high dose Ara-C (DHAP) followed by high-dose chemotherapy with autologous peripheral blood stem cell transplantation for mantle cell lymphoma Blood 92 suppl 1 1998 464a
109. J. Sweetenham R. Pearce G. Taghipour Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma—Outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: Results from the European Group for Blood and Marrow Transplantation J Clin Oncol 14 1996 2465 2472
110. The International Non-Hodgkin's Lymphoma Prognostic Factors Project A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 1993 987 994
111. The Non-Hodgkin's Lymphoma Classification Project A clinical evaluation of the International Lymphoma Study Group classification on non-Hodgkin's lymphoma Blood 89 1997 3909 3918
112. The Non-Hodgkin's Lymphoma Classification Project National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas Cancer 49 1982 2112 2135
113. H. Tilly P. Gaulard E. Lepage Primary anaplastic large-cell lymphoma in adults: Clinical presentation, immunophenotype, and outcome Blood 90 1997 3727 3734
114. L. Verdonck L. Wim M. van Putten Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma N Engl J Med 332 1995 1045 1051
115. L.F. Verdonck A.W. Dekker G.C. de Gast Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission J Clin Oncol 10 1992 644 666
116. J. Vose J. Anderson A. Kessinger High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma J Clin Oncol 11 1993 1846 1851
117. J. Vose P. Bierman J. Anderson Single-photon emission computed tomography gallium imaging versus computed tomography: Predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma J Clin Oncol 14 1996 2473 2479
118. J. Vose C. Peterson P. Bierman Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas Blood 76 1990 424 431
119. J. Vose J. Sharp W. Chan High-dose chemotherapy and autotransplant for non-Hodgkin's lymphoma: Randomized trial of peripheral blood versus bone marrow and evaluation of minimal residual disease Proceedings of the American Society of Clinical Oncology 16 1997 90a
120. D. Weisdorf J. Andersen J. Glick Survival after relapse of low-grade non-Hodgkin's lymphoma: Implications for marrow transplantation J Clin Oncol 10 1992 942 947
121. D.D. Weisenburger J.O. Armitage Mantle cell lymphoma–an entity comes of age [see comments] Blood 87 1996 4483 4494
122. A. Yuen O. Kamel J. Halpern Long-term survival after histological transformation of low-grade follicular lymphoma J Clin Oncol 13 1995 1726 1733
123. P.L. Zinzani M. Bendandi M. Martelli Anaplastic large-cell lymphoma: Clinical and prognostic evaluation of 90 adult patients [see comments] J Clin Oncol 14 1996 955 962
124. P.L. Zinzani M. Bendandi G. Visani Adult lymphoblastic lymphoma: Clinical features and prognostic factors in 53 patients Leuk Lymphoma 23 1996 577 582